XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
NOTE 7 - FAIR VALUE MEASUREMENTS
 
The carrying values of the Company’s financial instruments not required to be carried at fair value on a recurring basis approximate fair value due to their short maturities (i.e., accounts receivable, other assets, accounts payable and other liabilities) or the nature and terms of the obligation (i.e., other notes payable and mortgage notes payable).
 
The assets measured at fair value on a recurring basis are as follows:
 
As of
 
September 30, 2018
 
 
June 30, 2018
 
 
 
Total - Level 1
 
 
Total - Level 1
 
Assets:
 
 
 
 
 
 
Investment in marketable securities:
 
 
 
 
 
 
 
 
REITs and real estate companies
 
$
1,621,000
 
 
$
1,484,000
 
Healthcare
 
 
797,000
 
 
 
838,000
 
Technology
 
 
624,000
 
 
 
639,000
 
Basic materials
 
 
506,000
 
 
 
698,000
 
Other
 
 
921,000
 
 
 
780,000
 
 
 
$
4,469,000
 
 
$
4,439,000
 
 
The fair values of investments in marketable securities are determined by the most recently traded price of each security at the balance sheet date.
 
Financial assets that are measured at fair value on a non-recurring basis and are not included in the tables above include “Other investments, net (non-marketable securities),” that were initially measured at cost and have been written down to fair value as a result of impairment or adjusted to record the fair value of new instruments received (i.e., preferred shares) in exchange for old instruments (i.e., debt instruments). The following table shows the fair value hierarchy for these assets measured at fair value on a non-recurring basis as follows:
 
 
 
 
 
 
 
 
 
Net loss for the three months
 
Assets
 
Level 3
 
 
September 30, 2018
 
 
ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other non-marketable investments
 
$
424,000
 
 
$
424,000
 
 
$
-
 
 
 
 
 
 
 
 
 
 
Net loss for the three months
 
Assets
 
Level 3
 
 
June 30, 2018
 
 
ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other non-marketable investments
 
$
474,000
 
 
$
474,000
 
 
$
-
 
 
Other investments in non-marketable securities are carried at cost net of any impairment loss. The Company has no significant influence or control over the entities that issue these investments and holds less than 20%​​​​​​​ ownership in each of the investments. These investments are reviewed on a periodic basis for other-than-temporary impairment. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include but are not limited to: (i) the length of time an investment is in an unrealized loss position, (ii) the extent to which fair value is less than cost, (iii) the financial condition and near-term prospects of the issuer and (iv) our ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in fair value.